Channel address:
Categories:
Economics
Language: English
Subscribers:
1.05K
Description from channel
DISCALIMER: I AM NOT SEBI REGISTERED ANALYST. ALL POSTS ARE EDUCATIONAL PURPOSES. NON ADVISORY, DISCRETIONAL. NO CLAIMS, RIGHTS RESERVED. I AM NOT RESPONSIBLE FOR YOUR LOSSES.
Contact me @NiravShahSE
Ratings & Reviews
Reviews can be left only by registered users. All reviews are moderated by admins.
5 stars
1
4 stars
1
3 stars
1
2 stars
0
1 stars
0
The latest Messages 15
2022-01-10 12:56:46
Jubilant ingrevia may blast above 614.5...keep close watch and pyramid upwards
52 viewsNirav, 09:56
2022-01-08 10:16:14
FORTIS HEALTHCARE- VALUE PICK FOR LONG TERM INVESTMENTOne A group value investing stock which i am going to cover today is Fortis Healthcare.
Fortis Healthcare Limited (FHL) – an IHH Healthcare Berhad company – is a leading integrated healthcare services provider with 36 healthcare facilities (including projects under development), 3900 operational beds (including O&M model) and 428 network diagnostic centres. FHL is India's second largest healthcare chain having a North Indian skew with ~60% beds. FHL has a long and established track record having favourable hospital maturity mix profile with large network of healthcare facilities. It has presence across various healthcare verticals, including secondary, tertiary and diagnostics. Fortis Healthcare is well positioned to capitalise on the positive outlook for healthcare services - better affordability, widening medical insurance coverage, growing healthcare awareness and government boost.
With its corporate governance issues behind it, the association of FHL with IHH has provided an opportunity to gain from international experience and world class standards in patient care. Fortis Healthcare, under the new management undertook a comprehensive strategic review and prioritized key areas that would drive revenues and operational performance. The ongoing litigation at the Hon’ble Supreme Court has delayed the ability of the company to carry out the planned expansion activities which could further strengthen its operational performance and financial position.
Valuations & Recommendation:
Hospital business is well positioned and has demonstrated healthy operational efficiency with industry leading ARPOB, ALOS, capacity utilization. Addition of 1,300 beds in a phased manner over the next four-five years will help in strengthening its network. In case of diagnostics business, greater focus on B2C penetration through digital transformation coupled with expansion of collection centers is likely to support healthy growth trajectory for SRL. Diagnostic business is asset light, highly scalable business with high RoCE. Faster shift of unorganized business to organized players, potential consolidation, likely increase in preventive & health check-ups would benefit the large organized players like SRL. Moreover, management’s focus on cost optimization and productivity improvement add to these positives. Expecting margin improvement across segments, given increased focused on B2C volume in the diagnostics business and improving product mix in the hospital segment along with cost rationalization initiatives.
Fortis healthcare is a good bet on the structural long term growth story of Indian healthcare & diagnostics industry, considering its established presence across healthcare verticals, quality testing capabilities and structural changes under the new management. With reignited capex plans, cost control initiatives, focus on B2C and higher-end care, i believe there is a scope for re-rating of this stock.
With its current price of around Rs 287, it looks very attractive compared to the valuation with another organised player like Apollo Hospital. Not to forget that SRL diagnostic is part of Fortis Health care, if that business is spun off and listed seperately then chances of value unlocking are also very high. A horizon of 3-5 years invesetment in this stock may yield tremendous returns
579 viewsNirav, edited 07:16
2022-01-08 08:49:59
193 viewsNirav, 05:49
2022-01-07 12:22:51
Tatastllp 866...second target also achieved
219 viewsNirav, 09:22
2022-01-07 11:40:48
Tatastllp 828
228 viewsNirav, 08:40
2022-01-07 08:36:47
Tatastllp 795...first target achieved
236 viewsNirav, 05:36
2022-01-07 07:56:11
Tatastlllp 780
238 viewsNirav, 04:56
2022-01-06 16:26:25
Both rocketed after crossing our last levels
128 viewsNirav, 13:26
2022-01-06 16:23:17
Suggested last year
137 viewsNirav, 13:23
2022-01-06 16:18:43
Two of our suggested stock in our last year Multibagger pack almost doubled from the recommended price
139 viewsNirav, 13:18
S
